Candida dubliniensis fungemia: the first four cases in North America.
about
Comparison of the hydrophobic properties of Candida albicans and Candida dubliniensis.Serological differentiation of experimentally induced Candida dubliniensis and Candida albicans infectionsNovel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprintingMolecular mechanisms of fluconazole resistance in Candida dubliniensis isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasisCandida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland.Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcomePresence of Candida spp. in the oral cavity of heart transplantation patients.Susceptibility of Candida dubliniensis to salivary histatin 3.Fungal infections associated with HIV infection.Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo.Candida dubliniensis at a university hospital in Saudi Arabia.Candida dubliniensis infections in a pediatric population: retrospective identification from clinical laboratory isolates of Candida albicansRare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.The first Korean case of candidemia due to Candida dubliniensis.Resolution of discrepant results for Candida species identification by using DNA probes.Candida dubliniensis endophthalmitis: five cases over 15 years.Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program.The Candida dubliniensis CdCDR1 gene is not essential for fluconazole resistance.Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.Tween 80 opacity test responses of various Candida species.Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agarIsogenic strain construction and gene targeting in Candida dubliniensis.Rapid identification and differentiation of Candida albicans and Candida dubliniensis by capillary-based amplification and fluorescent probe hybridization.Differentiation of Candida dubliniensis from Candida albicans on Pal's agar.The first documented case of Candida dubliniensis leptomeningeal disease in an immunocompetent host.Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.Calcineurin controls drug tolerance, hyphal growth, and virulence in Candida dubliniensis.One-year prevalence of Candida dublinienis in a Dutch university hospital.First report of Candida dubliniensis in the Middle East.In vitro adhesion of oral Candida dubliniensis isolates to acrylic denture surfaces following brief exposure to sub-cidal concentrations of polyenes, azoles and chlorhexidine.Cell surface hydrophobicity of oral Candida dubliniensis isolates following limited exposure to sub-therapeutic concentrations of chlorhexidine gluconate.Prevalence of Candida dubliniensis among cancer patients in Kuwait: a 5-year retrospective study.Comparison of Candida dubliniensis and C. albicans based on polar lipid composition.Genotypic subgrouping of clinical isolates of Candida albicans and Candida dubliniensis by 25S intron analysis.Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.Candida dubliniensis endophthalmitis: first case in North America.Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection.Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
P2860
Q30306740-B697A414-773E-40F3-9F8C-F55664E14852Q33973230-26422BA8-1BFC-4252-9866-17115FD78CA0Q34041713-A2824344-7888-49B9-B92D-9FB640AED2AEQ34108536-BE8B3AEB-35B9-45B6-96AA-719CA30C98BAQ34187320-811E64BF-42A0-46CA-A188-BA0E65A8B5BFQ34194192-700C4171-9B79-41D1-AEB6-EB9D1B7BB674Q34510359-ACD81BC3-9B1B-40A4-A163-3FFB711DC7D2Q34579400-636E3149-B0C9-46B9-B60C-531918BE93F3Q34722920-B88FDC6E-581B-42E6-85A0-54AFDFDC9B72Q34775235-B23D41AA-657C-4DA6-8933-DD6910083CF7Q34947163-DA0D2510-CCD4-4D9D-9507-4713AA6774FFQ34992130-5BB67CC9-2A7D-456E-92B2-059E7CD253DFQ35156996-90C92C28-A54F-40CD-AC64-5D392B098744Q35912243-F72CCD5C-8473-42E1-B436-1F9CDC90035AQ35919856-36F079B6-16D2-4C13-8DAC-C3492D32B698Q36242432-1B3893E3-1F54-460A-8034-60FE577439F0Q37350247-00661010-9A2A-409B-85CD-D2F93A131A12Q37420953-0D9BB3A9-FEA3-4CF4-99D8-8A901A89C23EQ38363634-EC6CD91E-D1F3-449B-9FFC-1249610E87A9Q38954030-FDCE651C-A80F-4B1B-948D-F3FBDF95C30EQ39462645-E963C81C-4C43-49F2-9134-446FC8E2F724Q39463018-5BEF3A9E-BE43-4BB5-9474-71EFB80AA587Q39526406-CEBB73DC-9F1C-4751-B2D9-374476AEC654Q39695169-C223D5AA-341B-468F-92BC-AA5B5B290EFAQ40133507-EA1A75C8-1CDE-462D-91D3-BA0834C5FC76Q41814486-6214FABC-978D-4ADC-8E1A-7798A592AA8AQ41817884-2FE78C8B-E8C2-41ED-8A28-18F5F1FD3975Q41926458-494087D8-EB9D-4BC2-8D1D-B07035B9DD05Q42726904-39B34403-BA51-4EBD-8293-CE6E7247441EQ42727292-718F4438-0EE3-4F26-A948-C620E0D4741DQ42756747-9F10EE5E-DCE2-4C7F-9555-274C6570BB74Q43748574-F5856AF7-2B57-4E65-BB6F-C02808DF03E0Q43883282-EA0FEEFF-5271-4C71-A172-0EA66E0AAD56Q44188674-F7CFB133-9CC8-4466-AB1C-0356E230BD63Q44232195-E5C667FB-C62D-4CCA-8C48-F8EAC6B8E97AQ44658393-A7DADB1C-0503-4096-AC1D-039EB4D1F583Q44839949-62A3806E-9C95-4D06-BFA4-B60DB8B90DB9Q44972031-2573D0CA-A776-485D-893F-461D5CE70783Q45477525-2B82AA11-6CC9-4682-854D-ECFA633785B8Q46473999-CAA30F27-45F9-4D11-8936-581AE0D14120
P2860
Candida dubliniensis fungemia: the first four cases in North America.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Candida dubliniensis fungemia: the first four cases in North America.
@en
Candida dubliniensis fungemia: the first four cases in North America.
@nl
type
label
Candida dubliniensis fungemia: the first four cases in North America.
@en
Candida dubliniensis fungemia: the first four cases in North America.
@nl
prefLabel
Candida dubliniensis fungemia: the first four cases in North America.
@en
Candida dubliniensis fungemia: the first four cases in North America.
@nl
P2093
P2860
P356
P1476
Candida dubliniensis fungemia: the first four cases in North America.
@en
P2093
Harrison LH
Morrison CJ
Warnock DW
P2860
P356
10.3201/EID0601.000108
P577
2000-01-01T00:00:00Z